• Latest Posts

Novo Nordisk Foundation investing $200M for first quantum computer for life sciences research

More companies enter BioInnovation Institute Venture Lab program

Report shows growth of life sciences sector in eastern Denmark

Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments

Novo Nordisk Foundation Pumps €85M into Carbon Capture Research

Farxiga’s Approval Fuels Chronic Kidney Disease Comeback


Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

More News! 9 Oct 2019

Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing

FDA Greenlights First Oral Version of Novo Nordisk’s Type 2 Diabetes Drug

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease